2024 Recipient - Dr Zhongxin Zhou, formerly Gilead
Throughout the 27 years working in the pharmaceutical industry, Dr Zhou and his teams have contributed to the commercial launches of 20 novel drug substances all over the world that are used in many drug products for the treatment of diseases that have saved millions of peoples’ lives around the world.
He has led and directed the R&D efforts of more than 200 drug substances for clinical development and commercial supplies. He led the planning, design, and construction of two laboratory buildings that have won Big Project Sustainability awards.